Quest partners with MD Anderson to develop cancer risk blood test

Quest partners with MD Anderson to develop cancer risk blood test

Quest plans to refine, develop and validate the technology and is aiming to launch the test in North America next year.

Quest Partners With MD Anderson To Develop Cancer Risk Blood Test - Data Intelligence

Dive Brief: Quest Diagnostics has partnered with The University of Texas MD Anderson Cancer Center to develop a cancer risk blood test. The collaboration, which Quest disclosed Tuesday, builds on MD Anderson’s research into protein biomarkers that may indicate a patient is at high risk of cancer diagnosis in the coming years. MD Anderson’s approach is potentially a cheaper way than liquid biopsies to find patients who would benefit from convent…